As of January 22, 2025, Milestone Pharmaceuticals (MIST) has a market cap of $0.11 billion USD. According to our data, Milestone Pharmaceuticals is ranked No.7647 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.11 B |
-15.68%
|
Dec 31, 2024 | $0.13 B |
41.32%
|
Dec 29, 2023 | $89.06 M |
-57.83%
|
Dec 30, 2022 | $0.21 B |
-39.54%
|
Dec 31, 2021 | $0.35 B |
-2.24%
|
Dec 31, 2020 | $0.36 B |
-58.15%
|
Dec 31, 2019 | $0.85 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Market Cap | = | MIST Stock Price | * | MIST Shares Outstanding |
= | $1.99 | * | 53.33 M | |
= | $0.11 B |